SnapAV & Control4 Merge To Transform Smart Home Market
Professional surveillance and networking products manufacturer, SnapAV, and global smart home solutions provider Control4 have successfully completed their merger in an all-cash transaction of around $680 million.
The merger leverages both company’s strengths, which some commentators claim will become one of the strongest forces in the custom home automation market.
Both companies have a catalogue of in-house brands and third-party products, backed by product engineering teams, customer service, education and training programs, and in-field technical support.
SnapAV intends to invest further into the international markets which Control4 is already established in, including Australia, New Zealand, the UK, Ireland, China, Germany and Switzerland.
“SnapAV is committed to investing relentlessly in the success of its dealers and fuelling broad industry growth to better serve our shared customers,” Heyman said.
“We believe in the importance of professionally installed systems, and we are laying the groundwork to ensure those businesses success long into the future.”
“The smart home industry is poised for massive growth, and much of that growth will be driven and satisfied by professionals,” said John Heyman, SnapAV CEO.
“We are delivering a unified and integrated company that gives dealers one place to go for the best and broadest selection of products, greater technical support, most rewarding sales programs, robust training resources, and more.”
“We know this to be true – the number of connected devices in the home will continue to increase,” Kindel continued.
“We’re focused on the vision of making end-customers rave about our fantastic products and the great living experiences our dealers create with those products.”
“Through this merger, we will fulfil the true promise of the smart home.”
With a combined 1,200 employees, SnapAV CEO John Heyman will lead the merged teams as CEO, while former Control4 CEO Martin Plaehn joins the board of directors of SnapAV’s parent company.